38398225|t|The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells.
38398225|a|Serine-threonine protein kinases of the DYRK and CLK families regulate a variety of vital cellular functions. In particular, these enzymes phosphorylate proteins involved in pre-mRNA splicing. Targeting splicing with pharmacological DYRK/CLK inhibitors emerged as a promising anticancer strategy. Investigation of the pyrido[3,4-g]quinazoline scaffold led to the discovery of DYRK/CLK binders with differential potency against individual enzyme isoforms. Exploring the structure-activity relationship within this chemotype, we demonstrated that two structurally close compounds, pyrido[3,4-g]quinazoline-2,10-diamine 1 and 10-nitro pyrido[3,4-g]quinazoline-2-amine 2, differentially inhibited DYRK1-4 and CLK1-3 protein kinases in vitro. Unlike compound 1, compound 2 efficiently inhibited DYRK3 and CLK4 isoenzymes at nanomolar concentrations. Quantum chemical calculations, docking and molecular dynamic simulations of complexes of 1 and 2 with DYRK3 and CLK4 identified a dramatic difference in electron donor-acceptor properties critical for preferential interaction of 2 with these targets. Subsequent transcriptome and proteome analyses of patient-derived glioblastoma (GBM) neurospheres treated with 2 revealed that this compound impaired CLK4 interactions with spliceosomal proteins, thereby altering RNA splicing. Importantly, 2 affected the genes that perform critical functions for cancer cells including DNA damage response, p53 signaling and transcription. Altogether, these results provide a mechanistic basis for the therapeutic efficacy of 2 previously demonstrated in in vivo GBM models.
38398225	40	76	Pyrido[3,4-g]quinazoline Derivatives	Chemical	-
38398225	80	84	DYRK	Gene	1859
38398225	85	88	CLK	Gene	1195
38398225	118	130	Glioblastoma	Disease	MESH:D005909
38398225	178	182	DYRK	Gene	1859
38398225	187	190	CLK	Gene	1195
38398225	371	375	DYRK	Gene	1859
38398225	376	379	CLK	Gene	1195
38398225	456	480	pyrido[3,4-g]quinazoline	Chemical	-
38398225	514	518	DYRK	Gene	1859
38398225	519	522	CLK	Gene	1195
38398225	717	754	pyrido[3,4-g]quinazoline-2,10-diamine	Chemical	-
38398225	761	802	10-nitro pyrido[3,4-g]quinazoline-2-amine	Chemical	-
38398225	928	933	DYRK3	Gene	8444
38398225	938	942	CLK4	Gene	57396
38398225	1085	1090	DYRK3	Gene	8444
38398225	1095	1099	CLK4	Gene	57396
38398225	1284	1291	patient	Species	9606
38398225	1300	1312	glioblastoma	Disease	MESH:D005909
38398225	1314	1317	GBM	Disease	MESH:D005909
38398225	1384	1388	CLK4	Gene	57396
38398225	1531	1537	cancer	Disease	MESH:D009369
38398225	1575	1578	p53	Gene	7157
38398225	1731	1734	GBM	Disease	MESH:D005909
38398225	Association	MESH:D005909	57396
38398225	Association	MESH:D005909	1195
38398225	Association	MESH:D005909	1859

